Dacomitinib and gedatolisib in combination with fractionated radiation in head and neck cancer.

Wilson, George D; Wilson, Thomas G; Hanna, Alaa; Dabjan, Mohamad; Buelow, Katie; Torma, John; Marples, Brian; Galoforo, Sandra

Wilson, George D; Wilson, Thomas G; Hanna, Alaa; Dabjan, Mohamad; Buelow, Katie; Torma, John; Marples, Brian; Galoforo, Sandra.

Afiliação

Wilson GD; Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States.
Wilson TG; Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States.
Hanna A; Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States.
Dabjan M; Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States.
Buelow K; Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States.
Torma J; Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States.
Marples B; Department of Radiation Oncology, University of Rochester, Rochester, NY, United States.
Galoforo S; Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, United States.

Clin Transl Radiat Oncol ; 26: 15-23, 2021 Jan.

Article em En | MEDLINE | ID: mdl-33251343

Palavras-chave

Growth delay; Head and neck cancer; Radiation; Targeted agents; Xenografts

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Prevencao_e_fatores_de_risco / Agentes_cancerigenos / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Idioma: En Revista: Clin Transl Radiat Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google